Harmony Biosciences Holdings Inc
NASDAQ:HRMY

Watchlist Manager
Harmony Biosciences Holdings Inc Logo
Harmony Biosciences Holdings Inc
NASDAQ:HRMY
Watchlist
Price: 37.02 USD -1.07% Market Closed
Market Cap: 2.1B USD

Wall Street
Price Targets

HRMY Price Targets Summary
Harmony Biosciences Holdings Inc

Wall Street analysts forecast HRMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRMY is 47.11 USD with a low forecast of 32.32 USD and a high forecast of 65.1 USD.

Lowest
Price Target
32.32 USD
13% Downside
Average
Price Target
47.11 USD
27% Upside
Highest
Price Target
65.1 USD
76% Upside
Harmony Biosciences Holdings Inc Competitors:
Price Targets
UCB
Ucb SA
10% Upside
MARI
Marinomed Biotech AG
169% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
34% Upside
ACUTAAS
Acutaas Chemicals Ltd
7% Upside
867
China Medical System Holdings Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Harmony Biosciences Holdings Inc

For the last 5 years the compound annual growth rate for Harmony Biosciences Holdings Inc's revenue is 160%. The projected CAGR for the next 4 years is 17%.

160%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Harmony Biosciences Holdings Inc

The compound annual growth rate of Harmony Biosciences Holdings Inc's operating income for the next 4 years is 25%.

N/A
Past Growth
25%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Harmony Biosciences Holdings Inc

The compound annual growth rate of Harmony Biosciences Holdings Inc's net income for the next 4 years is 41%.

N/A
Past Growth
41%
Estimated Growth
Estimates Accuracy
4%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HRMY's stock price target?
Price Target
47.11 USD

According to Wall Street analysts, the average 1-year price target for HRMY is 47.11 USD with a low forecast of 32.32 USD and a high forecast of 65.1 USD.

What is Harmony Biosciences Holdings Inc's Revenue forecast?
Projected CAGR
17%

For the last 5 years the compound annual growth rate for Harmony Biosciences Holdings Inc's revenue is 160%. The projected CAGR for the next 4 years is 17%.

What is Harmony Biosciences Holdings Inc's Operating Income forecast?
Projected CAGR
25%

The compound annual growth rate of Harmony Biosciences Holdings Inc's operating income for the next 4 years is 25%.

What is Harmony Biosciences Holdings Inc's Net Income forecast?
Projected CAGR
41%

The compound annual growth rate of Harmony Biosciences Holdings Inc's net income for the next 4 years is 41%.

Back to Top